(Q41496310)

1 October 2017

Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis (English)

1 reference

1 October 2017

1 reference

3

A V Schally

1 reference

1 October 2017

D Kleinman

1

1 reference

1 October 2017

A Douvdevani

series ordinal

2

1 reference

1 October 2017

J Levy

series ordinal

4

1 reference

1 October 2017

Y Sharoni

series ordinal

5

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

American Journal of Obstetrics and Gynecology

1 October 2017

1 reference

1 October 2017

170

1 reference

1 October 2017

1 Pt 1

1 reference

1 October 2017

96-102

1 reference

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Treatment of breast cancer with gonadotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Membrane receptors for peptides in experimental and human pancreatic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Specific low affinity binding sites for gonadotropin-releasing hormone in human endometrial carcinomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Roles of antiestrogen binding sites in human endometrial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Effect of hormonal manipulation and doxorubicin administration on cell cycle kinetics of human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Histological changes in Dunning prostate tumors and testes of rats treated with LH-RH antagonist SB-75.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

Establishment of a cell line of human endometrial adenocarcinoma in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970391-4

10.1016/S0002-9378(94)70391-4

7 January 2021

Identifiers

DOI

1 reference

1 October 2017

1 reference